EyePoint (EYPT) Earnings Date & Reports

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

EYPT is expected to report earnings to fall 16.93% to -90 cents per share on November 04

Q3'26

Est.

$-0.91

Q2'26

Missed

by $0.15

Q1'26

Missed

by $0.17

Q4'25

Missed

by $0.06

Q3'25

Missed

by $0.08

The last earnings report on August 05 showed earnings per share of -109 cents, missing the estimate of -93 cents. With 5.24M shares outstanding, the current market capitalization sits at 458.65M.

View a ticker or compare two or three

EYPT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days